The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of dovitinib in recurrent glioblastoma.
 
Manmeet Singh Ahluwalia
Honoraria - Elekta; Sigma-Tau
Consulting or Advisory Role - Genentech/Roche; Monteris Medical; Novocure
Speakers' Bureau - Sigma-Tau
Research Funding - Boehringer Ingelheim; Lilly/ImClone; Novartis; Novocure; Spectrum Pharmaceuticals; TRACON Pharma
Travel, Accommodations, Expenses - Elekta
 
Nikolaos Papadantonakis
No Relationships to Disclose
 
Vyshak Alva Venur
No Relationships to Disclose
 
Cathy Schilero
No Relationships to Disclose
 
David M. Peereboom
Honoraria - Genentech; Merck KGaA
Consulting or Advisory Role - Novocure
Research Funding - Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
 
Glen Stevens
No Relationships to Disclose
 
Steven Rosenfeld
No Relationships to Disclose
 
Michael A. Vogelbaum
Leadership - Infusion Therapeutics
Stock and Other Ownership Interests - Infusion Therapeutics
Consulting or Advisory Role - Neuralstem
Research Funding - Infusion Therapeutics (Inst); Tocagen (Inst)
Patents, Royalties, Other Intellectual Property - Infusion Therapeutics INC
 
Paul Elson
No Relationships to Disclose
 
Andrew B. Nixon
Consulting or Advisory Role - GlaxoSmithKline; Novartis
Research Funding - Amgen; Novartis; Pfizer; TRACON Pharma
 
Keith McCrae
No Relationships to Disclose